Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
1.059
-0.091 (-7.92%)
Oct 22, 2026, 2:52 PM EDT - Market open
Purple Biotech Market Cap
Purple Biotech has a market cap or net worth of $9.65 million as of October 22, 2026. Its market cap has increased by 59.75% in one year.
Market Cap
9.65M
Enterprise Value
3.85M
1-Year Change
59.75%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since July 14, 2013, Purple Biotech's market cap has increased from $4.97M to $9.65M, an increase of 94.23%. That is a compound annual growth rate of 5.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 9.65M | 38.01% |
| Dec 31, 2025 | 7.00M | -36.83% |
| Dec 31, 2024 | 11.07M | -48.88% |
| Dec 31, 2023 | 21.67M | -19.15% |
| Dec 29, 2022 | 26.80M | -60.87% |
| Dec 30, 2021 | 68.47M | 2.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Phio Pharmaceuticals | 10.41M |
| Palatin Technologies | 10.31M |
| BioLineRx | 10.22M |
| Citius Pharmaceuticals | 10.18M |
| IN8bio | 10.15M |
| Ensysce Biosciences | 10.12M |
| GT Biopharma | 9.92M |
| CytoMed Therapeutics | 9.82M |